Global Market of Cancer Profiling Therapeutics is Likely to Experience Solid Growth: Projected to Bring in US$ 122,129.6 Mn Revenue by 2026

Rockville, US, 2018-May-04 — /EPR Network/ — A freshly compiled business intelligent report, titled “Cancer Profiling Market Research Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2026” has been publicized to the vast archive of Fact.MR online repository. This 170-page study delivers all the vital details and information required to know about cancer profiling market current as well as future prospects. The analysts of the study have gone through extensive research methodologies in order to generate data and information that reflects the latest market undercurrents and industry trends. For a deeper understanding of the market, a sub-category level analysis has been elaborated, by which readers and investors of the report will able to know that where the market stands to gain.

Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=358

According to a study by Fact.MR, the global market for cancer profiling is likely to experience solid growth. The global market for cancer profiling is also projected to bring in US$ 122,129.6 million revenue by 2026 end. Technological advancements, increasing cancer incidences, tumor profiling using biomarkers, the rise in funds for cancer research, are some of the major factors resulting in the growth of cancer profiling market. However, lack of skilled professionals and infrastructure are hampering the growth of the global market for cancer profiling.

Next-Generation Sequencing to Emerge as the Most-Preferred Technique in Cancer Profiling

Next-generation sequencing technique is likely to be the most-preferred cancer profiling technique. Experiencing a solid growth, next-generation sequencing technique is projected to exceed US$ 61,900 million revenue by 2026 end. Owing to the reduced sequencing cost, technology advancements in platforms used for sequencing, and rising awareness on next-generation sequencing services and products, the next-generation sequencing technique will experience growth in the market.

Pharmaceutical and Biotech Companies to Emerge as the Biggest End-User

Compared to the various end-users of cancer profiling, pharmaceutical and biotech companies are likely to emerge as the biggest users of cancer profiling. Pharmaceutical and biotech companies are projected to create an incremental opportunity surpassing US$ 40,600 million between 2017 and 2026. Factors such as offering better-targeted therapy and medicine for cancer treatment, correct prediction of various types of cancer, and reducing adverse drug reaction by offering correct dosage and formulation are driving the use of cancer profiling by pharmaceutical and biotech companies.

Cancer Profiling to Find Largest Application in Diagnosis

Cancer profiling is used for research, prognosis, personalized medicine, biomarker discovery. However, cancer profiling is likely to find the largest application in diagnosis. Gaining considerable growth, diagnosis is anticipated to create an absolute dollar opportunity of over US$ 32,200 million between 2017 and 2026. Cancer profiling plays an important role in diagnosis, as it helps physicians in understanding cancer tumor and identifying type of cancer. It also helps in taking appropriate decisions, avoiding ‘over-treatment’ of cancer patients.

Browse Full Report with TOC@ https://www.factmr.com/report/358/cancer-profiling-market

Table of Contents:

1. Global Economic Outlook
2. Global Cancer Profiling Market – Executive Summary
3. Global Cancer Profiling Market Overview
   3.1. Introduction
   3.1.1. Global Cancer Profiling Market Taxonomy
   3.1.2. Global Cancer Profiling Market Definition
   3.2. Global Cancer Profiling Market Size (US$ Mn) and Forecast, 2012-2026
   3.2.1. Global Cancer Profiling Market Y-o-Y Growth
   3.3. Global Cancer Profiling Market Dynamics
   3.4. Supply Chain
   3.5. Cost Structure
   3.6. Characteristics of Molecular Profiling Trials
   3.7. Three-Tiered Approach for Reporting Biomarkers in Tumor Profiling NGS Tests
   3.8. Recent breakthroughs in Cancer Profiling Market
   3.9. Patent Analysis
   3.10. Treatment Approvals
   3.11. Cancer Epidemiology
   3.12. PESTL Analysis
   3.13. Product Lifecycle
   3.14. Service Provider List
   3.15. Key Participants Market Presence (Intensity Map) By Region
4. Global Cancer Profiling Market Analysis and Forecast 2012-2026 
   4.1. Global Cancer Profiling Market Size and Forecast By Technique, 2012-2026
   4.1.1. Next-Generation Sequencing Market Size and Forecast, 2012-2026
   4.1.1.1. Revenue (US$ Mn) Comparison, By Region
   4.1.1.2. Market Share Comparison, By Region

Continued……

Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=358

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/